Schedule 13G ownership disclosure

ASTRIA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 04635X102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 1,960,135.00 · Class: 3.5%

  • Millennium Management LLC

    Shares: 1,994,503.00 · Class: 3.5%

  • Millennium Group Management LLC

    Shares: 1,994,503.00 · Class: 3.5%

  • Israel A. Englander

    Shares: 1,994,503.00 · Class: 3.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-006680
Form type
SCHEDULE 13G/A
Filer
Astria Therapeutics, Inc.
CIK
CIK 1454789
Filed
Jan 28, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub